Skip to main content
. 2018 Jan 5;32(4):820–829. doi: 10.1038/eye.2017.285

Figure 3.

Figure 3

Vitreous concentrations of VEGF, IL-1b and IL-1RA in No-DR, DME and Hr-PDR groups. (a) The comparison of vascular endothelial growth factors levels in vitreous reflux across no-DR, DME, and Hr-PDR. (b) The comparison of IL1b levels across no-DR, DME, and Hr-PDR groups. (c) The comparison of IL1RA levels across no-DR, DME, and Hr-PDR groups. DME, diabetic macular oedema; Hr-PDR, high-risk proliferative diabetic retinopathy groups; IL1b, interleukin 1b; IL1RA, interleukin 1 receptor antagonist; no-DR, no diabetic retinopathy.